MRI-Ultrasound fusion prostate biopsy

Abstract

MRI prostate has emerged as the most accurate imaging available for detection of significant prostate cancer. Standardized reporting using the The Prostate Imaging Reporting and Data System (PI-RADS) system for MRI prostate is important for clinical management and for professional communication. Besides diagnosis of prostate cancer, MRI prostate also enabled targeted prostate biopsy, and MRI-Ultrasound fusion biopsy has been increasingly utilized for targeting of suspicious MRI lesions during real-time ultrasound scanning of prostate. The elements of a successful MRI-Ultrasound fusion biopsy program include high quality MRI imaging and reporting, and the proper usage of fusion biopsy machines in achieving an accurate targeted biopsy.